Morgan Stanley (FRA:DWD) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:DWD Morgan Stanley FRA:DWD
71 GF Score
Price €193.95
GF Value €132.27
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Morgan Stanley Research & Development?

Morgan Stanley FRA:DWD -2.76% 71 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:DWD with a GF Score™ of 71/100 and a GF Value™ of €132.27 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Morgan Stanley's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Morgan Stanley  (FRA:DWD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Morgan Stanley Research & Development Related Terms

Morgan Stanley Research & Development Historical Data

* Premium members only.

The historical data trend for Morgan Stanley's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Morgan Stanley Research & Development Chart

Morgan Stanley Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Morgan Stanley Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:DWD
71GF Score
Morgan Stanley FRA:DWD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Morgan Stanley Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Morgan Stanley (FRA:DWD) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Morgan Stanley and its competitors.
Is Morgan Stanley's Research & Development too high?
Morgan Stanley's current Research & Development is €0 Mil. Overall, Morgan Stanley has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Morgan Stanley's Research & Development compare to GS and SCHW?
Morgan Stanley's Research & Development of €0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Morgan Stanley and its competitors. Morgan Stanley's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morgan Stanley stock overvalued right now?
Based on GuruFocus' analysis, Morgan Stanley (FRA:DWD) is currently considered Significantly Overvalued. The stock's GF Value™ is €132.27, compared to a current price of €193.95 — trading 46.6% above its estimated fair value. The current Research & Development is €0 Mil. Morgan Stanley's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Morgan Stanley (FRA:DWD), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Morgan Stanley (FRA:DWD) Overvalued in 2026?

Based on GuruFocus' analysis, Morgan Stanley stock appears to be overvalued. The current stock price of €193.95 is trading 46.6% above its estimated GF Value™ of €132.27. GuruFocus considers Morgan Stanley to be Significantly Overvalued.

Key valuation signals for FRA:DWD:

  • Research & Development: €0 Mil
  • GF Value™: €132.27 vs. price of €193.95 (46.6% above fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the FRA:DWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Morgan Stanley Business Description

Address 1585 Broadway, New York, NY, USA, 10036
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
71GF Score

Get the complete analysis for FRA:DWD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€193.95
Price
€132.27
GF Value